27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Shares of PPD (NASDAQ:PPD) were flat in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share increased 18.18% over the past year to $0.39, which beat the estimate of $0.36.
Revenue of $1,364,000,000 rose by 30.28% year over year, which beat the estimate of $1,280,000,000.
Outlook
The upcoming fiscal year's EPS expected to be between $1.37 and $1.45.
The upcoming fiscal year's revenue expected to be between $5,145,000,000 and $5,304,000,000.
Price Action
Company's 52-week high was at $38.76
52-week low: $10.61
Price action over last quarter: Up 9.56%
Company Description
PPD is a global contract research organization that provides clinical trial and laboratory services to pharmaceutical, device, and diagnostic firms. The clinical development services segment offers outsourced trial services, spanning early- and late-stage trials, as well as peri- and post-approval trials, and the laboratory services segment includes both advanced lab testing and central lab services. The company was taken private in 2011 and went public again in 2020.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!